JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

Search

Microbot Medical Inc

Fermé

2.82 6.42

Résumé

Variation du prix de l'action

24h

Actuel

Min

2.65

Max

2.89

Chiffres clés

By Trading Economics

Revenu

791K

-2.6M

Employés

20

EBITDA

-127K

-3.4M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+239.62% upside

Dividendes

By Dow Jones

Prochains Résultats

12 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

19M

111M

Ouverture précédente

-3.6

Clôture précédente

2.82

Score Technique

By Trading Central

Confiance

Neutral Evidence

Microbot Medical Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

5 août 2025, 23:11 UTC

Résultats

Australia's REA Hikes Dividend as Annual Profit Rises 23% -- Update

5 août 2025, 22:45 UTC

Résultats

Australia's REA Hikes Dividend as Annual Profit Rises 23%

5 août 2025, 22:39 UTC

Résultats

Great-West Lifeco Logs Lower 2Q Profit

5 août 2025, 21:32 UTC

Résultats

Coupang Posts Higher 2Q Sales Due to Customer Growth

6 août 2025, 00:00 UTC

Acquisitions, Fusions, Rachats

NFL to Take 10% Stake in Disney's ESPN -- WSJ

6 août 2025, 00:00 UTC

Acquisitions, Fusions, Rachats

The NFL Is Taking a 10% Stake in Disney's ESPN -- WSJ

6 août 2025, 00:00 UTC

Acquisitions, Fusions, Rachats

Disney to Take Control of NFL Network as Part of Agreement -- WSJ

6 août 2025, 00:00 UTC

Acquisitions, Fusions, Rachats

Disney, NFL Strike Wide-Reaching Media-Asset Deal -- WSJ

5 août 2025, 23:48 UTC

Market Talk

Nikkei May Decline Amid U.S. Economic Uncertainty -- Market Talk

5 août 2025, 23:40 UTC

Market Talk

Gold Edges Higher, Supported by Fed Rate-Cut Hopes -- Market Talk

5 août 2025, 23:19 UTC

Market Talk

Lindian Deal With Iluka Demonstrates Kangankunde Project Appeal -- Market Talk

5 août 2025, 23:03 UTC

Market Talk
Résultats

Advanced Micro Devices' Data-Center Story Seen as Promising -- Market Talk

5 août 2025, 22:22 UTC

Résultats

REA: Expectation of More Interest-Rate Cuts Likely to Support Buyer Demand>REA.AU

5 août 2025, 22:21 UTC

Résultats

REA Expects FY26 Listing Volumes Broadly Flat on FY25>REA.AU

5 août 2025, 22:20 UTC

Résultats

REA Expects September-Quarter Listings to Be Down on Year>REA.AU

5 août 2025, 22:18 UTC

Résultats

REA July 2025 New Residential Listings Down 8% on Year>REA.AU

5 août 2025, 22:17 UTC

Résultats

REA FY25 Australian Residential Listings Up 1% on Year>REA.AU

5 août 2025, 22:17 UTC

Résultats

REA FY25 India Revenue A$129M Vs. A$103M>REA.AU

5 août 2025, 22:16 UTC

Résultats

REA FY25 Core Australia Revenue A$1.54B Vs. A$1.35B>REA.AU

5 août 2025, 22:16 UTC

Résultats

REA FY25 Core Operations Net Profit A$564.4M Vs. A$460.5M>REA.AU

5 août 2025, 22:15 UTC

Résultats

REA Group FY25 Ebitda A$969.2M Vs. A$824.8M>REA.AU

5 août 2025, 22:13 UTC

Résultats

REA Group Raises Dividend to A$1.38 Vs. A$1.02 >REA.AU

5 août 2025, 22:13 UTC

Résultats

REA Group FY25 Rev A$1.67B Vs. A$1.45B >REA.AU

5 août 2025, 22:12 UTC

Résultats

REA FY25 Core Operations Net Profit A$564.4M Vs, A$460.5M>REA.AU

5 août 2025, 22:12 UTC

Résultats

REA Group FY25 Net A$677.9M Vs. Net A$302.8M >REA.AU

5 août 2025, 21:58 UTC

Résultats

Novo Nordisk's Earnings Come After a Dramatic Guidance Cut. What to Look for Now. -- Barrons.com

5 août 2025, 21:30 UTC

Résultats

AMD Gives a Strong Outlook. Why the Stock Is Falling. -- Barrons.com

5 août 2025, 21:26 UTC

Résultats

AMD CEO Expects Embedded Segment to Return to Sequential Growth in Back Half of 2025

5 août 2025, 21:23 UTC

Résultats

AMD CEO Sees Strong Customer Interest in MI400 Series for Large-Scale Deployments

5 août 2025, 21:17 UTC

Résultats

AMD Expects Steep Production Ramp for MI350 Series in Back Half of Year, CEO Says

Comparaison

Variation de prix

Microbot Medical Inc prévision

Objectif de Prix

By TipRanks

239.62% hausse

Prévisions sur 12 Mois

Moyen 9 USD  239.62%

Haut 9 USD

Bas 9 USD

Basé sur 1 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

1 ratings

1

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

2.52 / 2.57Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Very Strong Bullish Evidence

Long Terme

Weak Bullish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.